Recce Pharmaceuticals Ltd (RCE.AX)
AUD 0.45
(-3.23%)
AUD 0.45
(-3.23%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -22.05 Million AUD | -27.28% |
| 2023 | -17.32 Million AUD | -22.44% |
| 2022 | -14.15 Million AUD | 7.9% |
| 2021 | -15.36 Million AUD | -184.12% |
| 2020 | -5.4 Million AUD | -58.16% |
| 2019 | -3.41 Million AUD | -17.07% |
| 2018 | -2.92 Million AUD | 8.29% |
| 2017 | -3.18 Million AUD | 33.95% |
| 2016 | -4.82 Million AUD | -971.61% |
| 2015 | -449.91 Thousand AUD | -65.3% |
| 2014 | -272.18 Thousand AUD | 6.89% |
| 2013 | -292.32 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | -22.05 Million AUD | -27.28% |
| 2024 Q2 | -9.6 Million AUD | 0.0% |
| 2024 Q4 | -12.44 Million AUD | 0.0% |
| 2023 Q2 | -9.25 Million AUD | 0.0% |
| 2023 Q4 | -8.07 Million AUD | 0.0% |
| 2023 FY | -17.32 Million AUD | -22.44% |
| 2022 Q4 | -9.12 Million AUD | 0.0% |
| 2022 FY | -14.15 Million AUD | 7.9% |
| 2022 Q2 | -5.03 Million AUD | 0.0% |
| 2021 Q2 | -10.91 Million AUD | 0.0% |
| 2021 FY | -15.36 Million AUD | -184.12% |
| 2021 Q4 | -4.44 Million AUD | 0.0% |
| 2020 FY | -5.4 Million AUD | -58.16% |
| 2020 Q4 | -3.04 Million AUD | 0.0% |
| 2020 Q2 | -2.36 Million AUD | 0.0% |
| 2019 FY | -3.41 Million AUD | -17.07% |
| 2019 Q2 | -1.02 Million AUD | 0.0% |
| 2019 Q4 | -1.71 Million AUD | 0.0% |
| 2018 Q2 | -1.03 Million AUD | 0.0% |
| 2018 FY | -2.92 Million AUD | 8.29% |
| 2018 Q4 | -600.88 Thousand AUD | 0.0% |
| 2017 Q4 | -1.67 Million AUD | 0.0% |
| 2017 FY | -3.18 Million AUD | 33.95% |
| 2017 Q2 | -1.36 Million AUD | 0.0% |
| 2016 FY | -4.82 Million AUD | -971.61% |
| 2016 Q4 | -4.21 Million AUD | 0.0% |
| 2016 Q2 | -432.78 Thousand AUD | 0.0% |
| 2015 Q3 | - AUD | 100.0% |
| 2015 FY | -449.91 Thousand AUD | -65.3% |
| 2015 Q2 | -184.86 Thousand AUD | 0.0% |
| 2015 Q4 | -265.04 Thousand AUD | 0.0% |
| 2014 FY | -272.18 Thousand AUD | 6.89% |
| 2013 FY | -292.32 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 9.71 Million AUD | 326.945% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -1411.263% |
| Zelira Therapeutics Limited | -5.93 Million AUD | -271.344% |
| Biome Australia Limited | -1.91 Million AUD | -1052.56% |
| Patrys Limited | -3.53 Million AUD | -523.066% |
| Orthocell Limited | -11.68 Million AUD | -88.777% |
| Imugene Limited | -140.93 Million AUD | 84.353% |
| Noxopharm Limited | -7.53 Million AUD | -192.651% |
| PYC Therapeutics Limited | -38.85 Million AUD | 43.251% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | -79.137% |
| Prescient Therapeutics Limited | -7.18 Million AUD | -206.846% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | -204.931% |
| Cynata Therapeutics Limited | -8.8 Million AUD | -150.357% |
| CSL Limited | 5.64 Billion AUD | 100.39% |
| Arovella Therapeutics Limited | -7.19 Million AUD | -206.563% |
| Bio-Gene Technology Limited | -3.06 Million AUD | -620.049% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 144.867% |
| Starpharma Holdings Limited | -15.15 Million AUD | -45.466% |
| Nanollose Limited | -1.24 Million AUD | -1664.346% |
| Memphasys Limited | -2.7 Million AUD | -715.504% |
| Invex Therapeutics Ltd | -2.13 Million AUD | -933.51% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | -972.239% |
| Amplia Therapeutics Limited | -4.42 Million AUD | -398.336% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | -50.01% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | -667.325% |
| Race Oncology Limited | -13.38 Million AUD | -64.801% |
| Nyrada Inc. | -4.56 Million AUD | -383.545% |
| Telix Pharmaceuticals Limited | - AUD | Infinity% |
| Dimerix Limited | -25.05 Million AUD | 12.005% |
| PharmAust Limited | -6.65 Million AUD | -231.168% |
| Immutep Limited | -44.93 Million AUD | 50.929% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | 50.779% |
| Alterity Therapeutics Limited | -19.6 Million AUD | -12.497% |
| BTC Health Limited | 1.05 Million AUD | 2189.596% |
| Acrux Limited | -9.83 Million AUD | -124.235% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 109.759% |
| Biotron Limited | -5.15 Million AUD | -328.082% |
| Tissue Repair Ltd | -4.87 Million AUD | -352.245% |
| AdAlta Limited | -5.26 Million AUD | -319.098% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | 53.291% |
| Hexima Limited | -1 Million AUD | -2085.997% |
| AnteoTech Limited | -11.72 Million AUD | -88.045% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | 66.133% |
| Avecho Biotechnology Limited | -4.58 Million AUD | -380.504% |
| Actinogen Medical Limited | -12.83 Million AUD | -71.752% |
| Immuron Limited | -5.8 Million AUD | -280.121% |
| Argenica Therapeutics Limited | -5.67 Million AUD | -288.828% |